Phase 2 Cholangiocarcinoma trials recruiting now
All Cholangiocarcinoma trials, every phase
7
Phase 2 recruiting
Other phases for Cholangiocarcinoma
Phase 2 Cholangiocarcinoma trials
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Agnostic Therapy in Rare Solid Tumors
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Trop2-targeted immunoPET Imaging of Solid Tumors
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.